Alopecia areata is associated with impaired health-related quality of life: A survey of affected adults and children and their families - 16/08/18
Doi : 10.1016/j.jaad.2018.01.048
Lucy Y. Liu, MD a, Brett A. King, MD, PhD b, Brittany G. Craiglow, MD b, ⁎ 
b Department of Dermatology
a Yale University School of Medicine
∗Reprint requests: Brittany G. Craiglow, MD, Department of Dermatology, Yale University School of Medicine, PO Box 208059, New Haven, CT 06520Department of DermatologyYale University School of MedicinePO Box 208059New HavenCT06520
| Funding sources: Dr King received funding support from The Ranjini and Ajay Poddar Resource Fund for Dermatologic Diseases Research. Ms Liu received funding from the Yale University School of Medicine Medical Student Research Fellowship. |
|
| Disclosure: Dr King has served on advisory boards or is a consultant for Aclaris Therapeutics, Celgene, Concert Pharmaceuticals, Eli Lilly and Company, Pfizer, Regeneron Pharmaceuticals, and Roivant Sciences Ltd. Dr Craiglow has served on an advisory board, received honoraria from, and is a consultant for Pfizer. No other disclosures were made. |
|
| Parts of the results were presented at the 13th World Congress of Pediatric Dermatology, Chicago, IL; July 6-9, 2017. |
© 2018
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 79 - N° 3
P. 556 - septembre 2018 Retour au numéro
Article précédent
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Alexandra K. Rzepecki, Haiying Cheng, Beth N. McLellan
- A technique for more precise distinction between catagen and telogen human hair follicles ex vivo
- Irene Hernandez, Majid Alam, Christopher Platt, Jonathan Hardman, Eleanor Smart, Enrique Poblet, Marta Bertolini, Ralf Paus, Francisco Jimenez
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?